Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injury.

Kida Y, Ieronimakis N, Schrimpf C, Reyes M, Duffield JS.

J Am Soc Nephrol. 2013 Mar;24(4):559-72. doi: 10.1681/ASN.2012080871.

2.

Getting the "inside" scoop on ephrinB2 signaling in pericytes and the effect on peritubular capillary stability.

Basile DP, Yoder MC.

J Am Soc Nephrol. 2013 Mar;24(4):521-3. doi: 10.1681/ASN.2013020153. No abstract available.

3.

Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.

Füller T, Korff T, Kilian A, Dandekar G, Augustin HG.

J Cell Sci. 2003 Jun 15;116(Pt 12):2461-70.

4.

Attenuation of ephrinB2 reverse signaling decreases vascularized area and preretinal vascular tuft formation in the murine model of oxygen-induced retinopathy.

Taylor AC, Mendel TA, Mason KE, Degen KE, Yates PA, Peirce SM.

Invest Ophthalmol Vis Sci. 2012 Aug 13;53(9):5462-70. doi: 10.1167/iovs.11-8599.

5.

Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis.

Lin SL, Chang FC, Schrimpf C, Chen YT, Wu CF, Wu VC, Chiang WC, Kuhnert F, Kuo CJ, Chen YM, Wu KD, Tsai TJ, Duffield JS.

Am J Pathol. 2011 Feb;178(2):911-23. doi: 10.1016/j.ajpath.2010.10.012.

6.

Regulation of signaling interactions and receptor endocytosis in growing blood vessels.

Pitulescu ME, Adams RH.

Cell Adh Migr. 2014;8(4):366-77. doi: 10.4161/19336918.2014.970010. Review.

7.

Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.

Das A, Shergill U, Thakur L, Sinha S, Urrutia R, Mukhopadhyay D, Shah VH.

Am J Physiol Gastrointest Liver Physiol. 2010 Jun;298(6):G908-15. doi: 10.1152/ajpgi.00510.2009.

8.

EphB4 signaling is capable of mediating ephrinB2-induced inhibition of cell migration.

Sturz A, Bader B, Thierauch KH, Glienke J.

Biochem Biophys Res Commun. 2004 Jan 2;313(1):80-8.

PMID:
14672701
9.

EphrinB2-EphB4 signals regulate formation and maintenance of funnel-shaped valves in corneal lymphatic capillaries.

Katsuta H, Fukushima Y, Maruyama K, Hirashima M, Nishida K, Nishikawa S, Uemura A.

Invest Ophthalmol Vis Sci. 2013 Jun 12;54(6):4102-8. doi: 10.1167/iovs.12-11436.

PMID:
23696610
10.

EphB4 overexpression in B16 melanoma cells affects arterial-venous patterning in tumor angiogenesis.

Huang X, Yamada Y, Kidoya H, Naito H, Nagahama Y, Kong L, Katoh SY, Li WL, Ueno M, Takakura N.

Cancer Res. 2007 Oct 15;67(20):9800-8.

11.

Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury.

Schrimpf C, Xin C, Campanholle G, Gill SE, Stallcup W, Lin SL, Davis GE, Gharib SA, Humphreys BD, Duffield JS.

J Am Soc Nephrol. 2012 May;23(5):868-83. doi: 10.1681/ASN.2011080851.

12.

Id proteins regulate capillary repair and perivascular cell proliferation following ischemia-reperfusion injury.

Lee D, Shenoy S, Nigatu Y, Plotkin M.

PLoS One. 2014 Feb 7;9(2):e88417. doi: 10.1371/journal.pone.0088417.

13.

Modulation of ephrinB2 leads to increased angiogenesis in ischemic myocardium and endothelial cell proliferation.

Månsson-Broberg A, Siddiqui AJ, Genander M, Grinnemo KH, Hao X, Andersson AB, Wärdell E, Sylvén C, Corbascio M.

Biochem Biophys Res Commun. 2008 Aug 29;373(3):355-9. doi: 10.1016/j.bbrc.2008.06.036.

PMID:
18571496
14.

EphB4 forward-signaling regulates cardiac progenitor development in mouse ES cells.

Chen K, Bai H, Liu Y, Hoyle DL, Shen WF, Wu LQ, Wang ZZ.

J Cell Biochem. 2015 Mar;116(3):467-75. doi: 10.1002/jcb.25000.

15.

The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.

Kertesz N, Krasnoperov V, Reddy R, Leshanski L, Kumar SR, Zozulya S, Gill PS.

Blood. 2006 Mar 15;107(6):2330-8.

16.

EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.

Kim I, Ryu YS, Kwak HJ, Ahn SY, Oh JL, Yancopoulos GD, Gale NW, Koh GY.

FASEB J. 2002 Jul;16(9):1126-8.

17.

PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature.

Mäkinen T, Adams RH, Bailey J, Lu Q, Ziemiecki A, Alitalo K, Klein R, Wilkinson GA.

Genes Dev. 2005 Feb 1;19(3):397-410. Erratum in: Genes Dev. 2006 Jul 1;20(13):1829.

18.

Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis.

Liu S, Soong Y, Seshan SV, Szeto HH.

Am J Physiol Renal Physiol. 2014 May 1;306(9):F970-80. doi: 10.1152/ajprenal.00697.2013.

19.

The role played by perivascular cells in kidney interstitial injury.

Rojas A, Chang FC, Lin SL, Duffield JS.

Clin Nephrol. 2012 May;77(5):400-8. Review.

20.

Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.

Zamora DO, Davies MH, Planck SR, Rosenbaum JT, Powers MR.

Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2175-82.

PMID:
15914639
Items per page

Supplemental Content

Support Center